Stock Track | Schrodinger Plummets 5.77% Despite Expanding Toxicology Initiative with $9.5M Gates Grant

Stock Track11-18

Schrodinger Inc. (SDGR) saw its stock plummet 5.77% in pre-market trading on Monday, despite announcing an expansion and acceleration of its initiative to predict toxicology risk early in drug discovery, backed by an additional $9.5 million grant from the Bill & Melinda Gates Foundation.

The computational platform company is broadening its efforts to develop a solution designed to improve the properties of novel drug candidates and reduce the risk of development failures associated with off-target protein binding, which can lead to serious side effects. With the additional funding from the Gates Foundation, following an initial $10 million grant earlier this year, Schrodinger can now access relevant experimental data faster and extend the initiative's timeline to April 2026.

Once developed, the toxicology prediction technology will be made available to the Gates Foundation's grantees around the world to help accelerate the development of new drugs targeting diseases that disproportionately affect low- and middle-income countries. The tools will also be accessible to Schrodinger's software customers and utilized in the company's proprietary drug discovery programs and collaborations. The majority of revenue from the additional funding is expected to be recognized in 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113637614?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-18 23:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113637614","market":"hk","top_or_hot":-1,"title":"Stock Track | Schrodinger Plummets 5.77% Despite Expanding Toxicology Initiative with $9.5M Gates Grant","media":"Stock Track","content":"<p>Schrodinger Inc. (SDGR) saw its stock plummet 5.77% in pre-market trading on Monday, despite announcing an expansion and acceleration of its initiative to predict toxicology risk early in drug discovery, backed by an additional $9.5 million grant from the Bill & Melinda Gates Foundation.</p>\n\n<p>The computational platform company is broadening its efforts to develop a solution designed to improve the properties of novel drug candidates and reduce the risk of development failures associated with off-target protein binding, which can lead to serious side effects. With the additional funding from the Gates Foundation, following an initial $10 million grant earlier this year, Schrodinger can now access relevant experimental data faster and extend the initiative's timeline to April 2026.</p>\n\n<p>Once developed, the toxicology prediction technology will be made available to the Gates Foundation's grantees around the world to help accelerate the development of new drugs targeting diseases that disproportionately affect low- and middle-income countries. The tools will also be accessible to Schrodinger's software customers and utilized in the company's proprietary drug discovery programs and collaborations. The majority of revenue from the additional funding is expected to be recognized in 2025.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Schrodinger Plummets 5.77% Despite Expanding Toxicology Initiative with $9.5M Gates Grant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Schrodinger Plummets 5.77% Despite Expanding Toxicology Initiative with $9.5M Gates Grant\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-18 23:18 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Schrodinger Inc. (SDGR) saw its stock plummet 5.77% in pre-market trading on Monday, despite announcing an expansion and acceleration of its initiative to predict toxicology risk early in drug ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SDGR","symbol_name":"Schrodinger Inc.","start_time":0,"source_url":"","article_id":"1113637614","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113637614","pubTimestamp":1731943122,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Schrodinger Inc.  saw its stock plummet 5.77% in pre-market trading on Monday, despite announcing an expansion and acceleration of its initiative to predict toxicology risk early in drug discovery, backed by an additional $9.5 million grant from the Bill & Melinda Gates Foundation.The computational platform company is broadening its efforts to develop a solution designed to improve the properties of novel drug candidates and reduce the risk of development failures associated with off-target prot","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SDGR":"Schrodinger Inc."},"translate_title":"尽管盖茨拨款950万美元扩大了毒理学计划，但薛定谔股价仍暴跌5.77%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SDGR":1},"content_text":"Schrodinger Inc. (SDGR) saw its stock plummet 5.77% in pre-market trading on Monday, despite announcing an expansion and acceleration of its initiative to predict toxicology risk early in drug discovery, backed by an additional $9.5 million grant from the Bill & Melinda Gates Foundation.\nThe computational platform company is broadening its efforts to develop a solution designed to improve the properties of novel drug candidates and reduce the risk of development failures associated with off-target protein binding, which can lead to serious side effects. With the additional funding from the Gates Foundation, following an initial $10 million grant earlier this year, Schrodinger can now access relevant experimental data faster and extend the initiative's timeline to April 2026.\nOnce developed, the toxicology prediction technology will be made available to the Gates Foundation's grantees around the world to help accelerate the development of new drugs targeting diseases that disproportionately affect low- and middle-income countries. The tools will also be accessible to Schrodinger's software customers and utilized in the company's proprietary drug discovery programs and collaborations. The majority of revenue from the additional funding is expected to be recognized in 2025.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113637614"}